Cardiovascular safety - Update from up to 6 years of treatment with baricitinib in rheumatoid arthritis clinical trials
Main Authors: | , , , , , , , |
---|---|
Format: | Conference item |
Published: |
Wiley
2018
|
Main Authors: | , , , , , , , |
---|---|
Format: | Conference item |
Published: |
Wiley
2018
|